Almirall announces filing Sativex® regulatory submission

· Sativex ® has proven to be effective for the treatment of spasticity in multiple sclerosis, in a recent phase III study developed with patients who had failed to gain improvement with other treatments

The release as fetched from its publisher. almirall.com ↗